Ultrasound-guided pain management for liver cancer surgery
The Role of Continuous Low Serratus Anterior Plane Block in Hepatocellular Carcinoma Surgery: a Randomised Clinical Trial.
This study tests if using an ultrasound-guided pain relief method during liver cancer surgery can help patients feel less pain and recover better compared to a different pain management approach.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | The First People's Hospital of Neijiang Academic / other |
| Locations | 1 site (Neijiang, Sichuan) |
| Trial ID | NCT05531864 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of an ultrasound-guided continuous low serratus anterior plane block for pain management in patients undergoing surgery for hepatocellular carcinoma. Patients are randomly assigned to receive either a continuous block or a single block combined with another technique. Key metrics such as operation time, anesthesia duration, and pain scores are recorded to evaluate the efficacy of the pain management approach. The study aims to improve postoperative analgesia and assess any potential impacts on liver function.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-60 with hepatocellular carcinoma and a BMI between 18-29.
Not a fit: Patients with severe comorbidities or those with a history of anesthetic allergies may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance pain management and recovery for patients undergoing liver cancer surgery.
How similar studies have performed: Similar studies have shown promise in using ultrasound-guided blocks for pain management, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-60 years; 2. ASAI-II; 3. BMI: 18-29 kg/m2 Exclusion Criteria: 1. Combined cardiac, cerebral, hepatic, and renal failure; 2. Comorbid psychiatric and neuromuscular disorders; 3. A history of allergy to anesthetic drugs; 4. Participation in other recent clinical or drug trials.
Where this trial is running
Neijiang, Sichuan
- The First People's Hospital of Neijiang — Neijiang, Sichuan, China (Recruiting)
Study contacts
- Study coordinator: Jiang Fei
- Email: 1277636690@qq.com
- Phone: 18283236053
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.